开始生物治疗的性结肠炎或克罗恩病患者疲劳的变化
Edouard Louis1, Peter Bossuyt2, Arnaud Colard3
1Department of Gastroenterology, University Hospital CHU of Liège, Liège, Belgium.
概括
生物治疗在6个月内改善了炎症性肠病 (IBD) 患者的疲劳. 实现临床缓解显著增加疲劳消失和改善生活质量.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 临床研究 临床研究
背景情况:
- 疲劳是炎症性肠道疾病 (IBD) 的普遍症状,显著影响患者的生活质量 (QoL).
- 了解治疗期间的疲劳动力学对于改善IBD患者的治疗结果至关重要.
研究的目的:
- 在开始生物治疗的性结肠炎 (UC) 或克罗恩病 (CD) 患者中研究疲劳的进展.
- 确定影响生物治疗IBD患者疲劳结果的关键因素.
主要方法:
- 一项前性,现实世界的研究,涉及到患有UC或CD的比利时成年患者.
- 使用慢性疾病治疗-疲劳 (FACIT-F) 的功能评估和通过短炎性肠病问卷的QoL来评估疲劳.
- 使用多变量回归分析来确定与疲劳结果相关的因素.
主要成果:
- 分析了465名患者 (174名UC,291名CD),显示在开始生物治疗6个月内疲劳改善,随后稳定.
- 临床缓解与更高的疲劳消失率和更低的疲劳持续率密切相关.
- 与持续疲劳的患者相比,疲劳改善与显著更大的QOL增强相关.
结论:
- 实践数据表明,生物治疗可以部分缓解IBD患者的疲劳,特别是在前六个月内.
- 临床缓解成为实现疲劳解决和防止其复发的关键因素.
- 需要进一步调查,以充分阐明导致IBD患者疲劳的多方面的因素.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315


